Updates in Molecular Pathology of Central Nervous System Gliomas in Adults

Michael Punsoni, John E. Donahue, Heinrich D. Elinzano, Timothy Kinsella

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Central nervous system (CNS) tumors are a heterogeneous group of neoplasms divided into two broad categories, glial and non-glial. Non-glial tumors are derived from such diverse structures as the pineal gland, meninges, germ cells, and hematopoietic cells, as well as metastases. Primary glial neoplasms, or those which originate from astrocytes, oligodendrocytes, or ependymal cells, include astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Each entity has a unique morphology and pattern of biologic behavior which portends a distinct prognosis and outcome. Individual outcomes show some variability based on tumor location and age of symptom onset; however, the underlying aggressiveness of the tumor often dictates the time course of the disease. With the advent and widespread use of fluorescent in-situ hybridization and polymerase chain reaction (PCR) techniques, molecular phenotyping of brain tumors has become mainstream and is now an integral part of patient care. The molecular genetics of CNS tumors is a rapidly growing field, and the volume of discoveries is growing at an ever increasing rate, compelling the need for updates in this exciting area of science.

Original languageEnglish (US)
Pages (from-to)17-19
Number of pages3
JournalRhode Island medical journal (2013)
Volume98
Issue number11
StatePublished - Nov 2 2015

Fingerprint

Molecular Pathology
Glioma
Central Nervous System
Central Nervous System Neoplasms
Neoplasms
Neuroglia
Oligodendroglioma
Ependymoma
Meninges
Pineal Gland
Oligodendroglia
Astrocytoma
Fluorescence In Situ Hybridization
Age of Onset
Germ Cells
Brain Neoplasms
Astrocytes
Molecular Biology
Patient Care
Neoplasm Metastasis

Keywords

  • 1p19q
  • Glioma
  • IDH1
  • MGMT
  • astrocytoma
  • glioblastoma
  • oligodendroglioma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Updates in Molecular Pathology of Central Nervous System Gliomas in Adults. / Punsoni, Michael; Donahue, John E.; Elinzano, Heinrich D.; Kinsella, Timothy.

In: Rhode Island medical journal (2013), Vol. 98, No. 11, 02.11.2015, p. 17-19.

Research output: Contribution to journalArticle

Punsoni, M, Donahue, JE, Elinzano, HD & Kinsella, T 2015, 'Updates in Molecular Pathology of Central Nervous System Gliomas in Adults', Rhode Island medical journal (2013), vol. 98, no. 11, pp. 17-19.
Punsoni, Michael ; Donahue, John E. ; Elinzano, Heinrich D. ; Kinsella, Timothy. / Updates in Molecular Pathology of Central Nervous System Gliomas in Adults. In: Rhode Island medical journal (2013). 2015 ; Vol. 98, No. 11. pp. 17-19.
@article{5cf3c1f1e9624d2c8ba03f7440986c9a,
title = "Updates in Molecular Pathology of Central Nervous System Gliomas in Adults",
abstract = "Central nervous system (CNS) tumors are a heterogeneous group of neoplasms divided into two broad categories, glial and non-glial. Non-glial tumors are derived from such diverse structures as the pineal gland, meninges, germ cells, and hematopoietic cells, as well as metastases. Primary glial neoplasms, or those which originate from astrocytes, oligodendrocytes, or ependymal cells, include astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Each entity has a unique morphology and pattern of biologic behavior which portends a distinct prognosis and outcome. Individual outcomes show some variability based on tumor location and age of symptom onset; however, the underlying aggressiveness of the tumor often dictates the time course of the disease. With the advent and widespread use of fluorescent in-situ hybridization and polymerase chain reaction (PCR) techniques, molecular phenotyping of brain tumors has become mainstream and is now an integral part of patient care. The molecular genetics of CNS tumors is a rapidly growing field, and the volume of discoveries is growing at an ever increasing rate, compelling the need for updates in this exciting area of science.",
keywords = "1p19q, Glioma, IDH1, MGMT, astrocytoma, glioblastoma, oligodendroglioma",
author = "Michael Punsoni and Donahue, {John E.} and Elinzano, {Heinrich D.} and Timothy Kinsella",
year = "2015",
month = "11",
day = "2",
language = "English (US)",
volume = "98",
pages = "17--19",
journal = "Rhode Island medicine",
issn = "2327-2228",
publisher = "Rhode Island Medical Society",
number = "11",

}

TY - JOUR

T1 - Updates in Molecular Pathology of Central Nervous System Gliomas in Adults

AU - Punsoni, Michael

AU - Donahue, John E.

AU - Elinzano, Heinrich D.

AU - Kinsella, Timothy

PY - 2015/11/2

Y1 - 2015/11/2

N2 - Central nervous system (CNS) tumors are a heterogeneous group of neoplasms divided into two broad categories, glial and non-glial. Non-glial tumors are derived from such diverse structures as the pineal gland, meninges, germ cells, and hematopoietic cells, as well as metastases. Primary glial neoplasms, or those which originate from astrocytes, oligodendrocytes, or ependymal cells, include astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Each entity has a unique morphology and pattern of biologic behavior which portends a distinct prognosis and outcome. Individual outcomes show some variability based on tumor location and age of symptom onset; however, the underlying aggressiveness of the tumor often dictates the time course of the disease. With the advent and widespread use of fluorescent in-situ hybridization and polymerase chain reaction (PCR) techniques, molecular phenotyping of brain tumors has become mainstream and is now an integral part of patient care. The molecular genetics of CNS tumors is a rapidly growing field, and the volume of discoveries is growing at an ever increasing rate, compelling the need for updates in this exciting area of science.

AB - Central nervous system (CNS) tumors are a heterogeneous group of neoplasms divided into two broad categories, glial and non-glial. Non-glial tumors are derived from such diverse structures as the pineal gland, meninges, germ cells, and hematopoietic cells, as well as metastases. Primary glial neoplasms, or those which originate from astrocytes, oligodendrocytes, or ependymal cells, include astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Each entity has a unique morphology and pattern of biologic behavior which portends a distinct prognosis and outcome. Individual outcomes show some variability based on tumor location and age of symptom onset; however, the underlying aggressiveness of the tumor often dictates the time course of the disease. With the advent and widespread use of fluorescent in-situ hybridization and polymerase chain reaction (PCR) techniques, molecular phenotyping of brain tumors has become mainstream and is now an integral part of patient care. The molecular genetics of CNS tumors is a rapidly growing field, and the volume of discoveries is growing at an ever increasing rate, compelling the need for updates in this exciting area of science.

KW - 1p19q

KW - Glioma

KW - IDH1

KW - MGMT

KW - astrocytoma

KW - glioblastoma

KW - oligodendroglioma

UR - http://www.scopus.com/inward/record.url?scp=85018526365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018526365&partnerID=8YFLogxK

M3 - Article

C2 - 26517249

AN - SCOPUS:85018526365

VL - 98

SP - 17

EP - 19

JO - Rhode Island medicine

JF - Rhode Island medicine

SN - 2327-2228

IS - 11

ER -